Cargando…

Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro

The development of clinically actionable pharmaceuticals against coronavirus disease (COVID-19); an infectious disease caused by the SARS-CoV-2 virus is very important for ending the pandemic. Coronavirus spike glycoprotein (GP)-Receptor Binding Domain (RBD) and its interaction with host receptor an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omotuyi, Olaposi, Olatunji, Olusina M., Nash, Oyekanmi, Oyinloye, Babatunji, Soremekun, Opeyemi, Ijagbuji, Ayodeji, Fatumo, Segun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851952/ https://www.ncbi.nlm.nih.gov/pubmed/36682669 http://dx.doi.org/10.1016/j.micpath.2023.105994

Ejemplares similares

SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody
por: Omotuyi, Olaposi, et al.
Publicado: (2022)

In-silico analysis reveals druggable single nucleotide polymorphisms in angiotensin 1 converting enzyme involved in the onset of blood pressure
por: Udosen, Brenda, et al.
Publicado: (2021)

Meta-Analysis and Multivariate GWAS Analyses in 77,850 Individuals of African Ancestry Identify Novel Variants Associated with Blood Pressure Traits
por: Udosen, Brenda, et al.
Publicado: (2023)

Genome-Wide Association and Mendelian Randomization Analysis Reveal the Causal Relationship Between White Blood Cell Subtypes and Asthma in Africans
por: Soremekun, Opeyemi, et al.
Publicado: (2021)

Multivariate GWAS analysis reveals loci associated with liver functions in continental African populations
por: Soremekun, Chisom, et al.
Publicado: (2023)

Chromolaena odorata flavonoids attenuate experimental nephropathy: Involvement of pro-inflammatory genes downregulation
por: Omotuyi, Olaposi Idowu, et al.
Publicado: (2020)

Identification of promising high-affinity inhibitors of SARS-CoV-2 main protease from African Natural Products Databases by Virtual Screening
por: DIABATE, Oudou, et al.
Publicado: (2023)

Genetically Predicted Lipid Traits, Diabetes Mellitus Liability and Carotid Intima-media Thickness in African Ancestry Individuals: A Mendelian Randomization Study
por: Soremekun, Opeyemi, et al.
Publicado: (2022)

Leveraging information between multiple population groups and traits improves fine-mapping resolution
por: Zhou, Feng, et al.
Publicado: (2023)

Entropic contribution of ACE2 glycans to RBD binding
por: Mugnai, Mauro L., et al.
Publicado: (2023)

Meta-analysis of African ancestry genome-wide association studies identified novel locus and validates multiple loci associated with kidney function
por: Kintu, Christopher, et al.
Publicado: (2023)

Scanning the RBD-ACE2 molecular interactions in Omicron variant
por: Rath, Soumya Lipsa, et al.
Publicado: (2022)

In silico study of intrinsic dynamics of full-length apo-ACE2 and RBD-ACE2 complex
por: Liu, Qing, et al.
Publicado: (2021)

Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study
por: Soremekun, Opeyemi, et al.
Publicado: (2022)

A Mendelian randomization study of genetic liability to post-traumatic stress disorder and risk of ischemic stroke
por: Soremekun, Opeyemi, et al.
Publicado: (2023)

Complimentary Methods for Multivariate Genome-Wide Association Study Identify New Susceptibility Genes for Blood Cell Traits
por: Fatumo, Segun, et al.
Publicado: (2019)

Molecular Dynamic Simulation Reveals Structure Differences in APOL1 Variants and Implication in Pathogenesis of Chronic Kidney Disease
por: Mayanja, Richard, et al.
Publicado: (2022)

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
por: Ching, Wai-Yim, et al.
Publicado: (2022)

Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction
por: Brown, Emily E. F., et al.
Publicado: (2021)

Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
por: Lan, Jun, et al.
Publicado: (2022)

Cross-species binding spectrum of ACE2 to SARS-CoV-2 RBD
por: Liao, Xihao, et al.
Publicado: (2022)

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2
por: Carter, Camryn, et al.
Publicado: (2023)

Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach
por: Hakami, Abdulrahim R.
Publicado: (2022)

Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
por: Liu, Xiaofeng, et al.
Publicado: (2023)

Lys39-Lysophosphatidate Carbonyl Oxygen Interaction Locks LPA(1) N-terminal Cap to the Orthosteric Site and partners Arg124 During Receptor Activation
por: Omotuyi, Olaposi I., et al.
Publicado: (2015)

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
por: Junker, Daniel, et al.
Publicado: (2022)

RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor
por: Sinha, Siddharth, et al.
Publicado: (2021)

Advanced Analysis of Biosensor Data for SARS-CoV-2 RBD and ACE2 Interactions
por: Forssén, Patrik, et al.
Publicado: (2020)

Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding
por: Yang, Li Jun, et al.
Publicado: (2021)

SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility
por: Valério, Mariana, et al.
Publicado: (2022)

The impact of mutation sets in receptor-binding domain of SARS-CoV-2 variants on the stability of RBD–ACE2 complex
por: Peka, Mykyta, et al.
Publicado: (2023)

Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2
por: Nguyen, Kien, et al.
Publicado: (2021)

Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2
por: Nguyen, Kien, et al.
Publicado: (2021)

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
por: Haycroft, Ebene R., et al.
Publicado: (2023)

Multi-trait discovery and fine-mapping of lipid loci in 125,000 individuals of African ancestry
por: Kamiza, Abram Bunya, et al.
Publicado: (2023)

Small molecule therapeutics to destabilize the ACE2-RBD complex: A molecular dynamics study
por: Razizadeh, Meghdad, et al.
Publicado: (2021)

Epstein-Barr virus, human papillomavirus and herpes simplex virus 2 co-presence severely dysregulates miRNA expression
por: Okoye, Jude O., et al.
Publicado: (2021)

Carotenoid-Enriched Fractions From Spondias mombin Demonstrate HER2 ATP Kinase Domain Inhibition: Computational and In Vivo Animal Model of Breast Carcinoma Studies
por: Metibemu, Damilohun Samuel, et al.
Publicado: (2021)

Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2
por: Rathod, Shravan B., et al.
Publicado: (2020)

Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug
por: Benítez-Cardoza, Claudia Guadalupe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fbrj95dv8lta82g9cjt4r04gsc